Advertisement

Indian

Over 45,000 cases of mucormycosis reported in India: Health ministry tells Rajya Sabha

Mucormycosis and other fungal infections are most commonly seen as an opportunistic infection. They are found in those with low underlying immunity either due to a diabetes, cancers particularly hematological malignancies, etc. or as a side effect of prolonged/irrational use of certain drugs like steroids, immunosuppressive drugs for management of other disorders including Covid-19, the minister explained.

Allow life insurers to sell pension-based health policies: HDFC Life Chairman

”Across the world, both pension and health cover are very much part of life insurance, as they protect people from longevity and morbidity risks.Hence, allowing life insurers to distribute products such as health indemnity, NPS would help improve the much-needed insurance reach across the country,” he said.

48.68 crore Covid vaccine doses manufactured in India: Govt

Under the ”Mission COVID Suraksha, facility augmentation for production of Covaxin is being supported, whereby Bharat Biotech and three public sector enterprises (PSEs) — Haffkine Biopharmaceutical Corporation Limited in Mumbai, Indian Immunologicals Limited (IIL) in Hyderabad and Bharat Immunologicals Biologicals Limited (BIBCOL) in Bulandshahr — are being supported.

International

Tesla rolls out insurance in California

Chief Executive Elon Musk has been one of the strongest proponents of the idea that car insurance rates should plummet as driver-assist and self-driving technology become standard. Tesla said rates of its new plan were as much as 20% lower than those of rivals but did not provide comparisons.

More favorable pricing permeates global reinsurance industry, but is it sustainable

Third-party capital continues to proliferate as investor interest has increased alongside more varied reinsurance structures, and has become more closely aligned with traditional reinsurance capital. Despite the capital markets’ increased influence, dedicated reinsurance capacity essentially remained flat in 2018, at $436 billion, with a single-digit percentage increase in convergence capital to $95 billion from $87 billion in 2017.

Briefs

No Results Found

The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.

Events

No Results Found

The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.

Advertisement

Articles

No Results Found

The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.

Features

No Results Found

The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.

Data

No Results Found

The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.

Interviews

No Results Found

The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.

Facts

No Results Found

The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.